Stephens Has Lowered Expectations for Tenet Healthcare (NYSE:THC) Stock Price

Tenet Healthcare (NYSE:THC) had its target price cut by stock analysts at Stephens from $275.00 to $260.00 in a report issued on Monday, Marketbeat Ratings reports. The firm currently has an “overweight” rating on the stock. Stephens’ price target points to a potential upside of 41.90% from the company’s current price.

A number of other equities research analysts also recently weighed in on the company. KeyCorp lowered their price target on Tenet Healthcare from $250.00 to $225.00 and set an “overweight” rating for the company in a report on Friday. Leerink Partners boosted their price target on Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a report on Friday, February 20th. Mizuho boosted their price target on Tenet Healthcare from $235.00 to $265.00 and gave the company an “outperform” rating in a report on Thursday, March 12th. UBS Group boosted their price objective on Tenet Healthcare from $260.00 to $288.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Finally, Wells Fargo & Company reduced their price objective on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a research report on Friday. Nineteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat.com, Tenet Healthcare has a consensus rating of “Moderate Buy” and a consensus price target of $242.89.

Tenet Healthcare Price Performance

Shares of NYSE THC opened at $183.23 on Monday. Tenet Healthcare has a twelve month low of $145.27 and a twelve month high of $247.21. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The company has a market capitalization of $16.05 billion, a price-to-earnings ratio of 9.53, a price-to-earnings-growth ratio of 1.37 and a beta of 1.30. The business has a 50 day simple moving average of $207.31 and a 200-day simple moving average of $204.33.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, April 30th. The company reported $4.82 earnings per share for the quarter, beating analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The business had revenue of $5.37 billion during the quarter, compared to the consensus estimate of $5.39 billion. During the same period in the previous year, the business earned $4.36 EPS. The business’s quarterly revenue was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, equities research analysts expect that Tenet Healthcare will post 17.42 earnings per share for the current year.

Insiders Place Their Bets

In other Tenet Healthcare news, EVP Thomas W. Arnst sold 24,000 shares of the business’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $234.04, for a total transaction of $5,616,960.00. Following the completion of the transaction, the executive vice president owned 8,012 shares in the company, valued at approximately $1,875,128.48. The trade was a 74.97% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider R. Scott Ramsey sold 8,017 shares of the business’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 46,517 shares of company stock worth $10,943,111. 0.81% of the stock is owned by company insiders.

Institutional Trading of Tenet Healthcare

Hedge funds and other institutional investors have recently modified their holdings of the company. Triumph Capital Management bought a new stake in shares of Tenet Healthcare in the 3rd quarter worth $25,000. Activest Wealth Management bought a new stake in shares of Tenet Healthcare in the 4th quarter worth $26,000. Elyxium Wealth LLC bought a new stake in shares of Tenet Healthcare in the 4th quarter worth $29,000. William B. Walkup & Associates Inc. bought a new stake in shares of Tenet Healthcare in the 3rd quarter worth $32,000. Finally, Canada Pension Plan Investment Board bought a new stake in shares of Tenet Healthcare in the 2nd quarter worth $35,000. Institutional investors own 95.44% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.